[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2014 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 3.09%
YoY- 1.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 474,312 318,542 241,705 167,916 155,561 133,242 140,128 22.51%
PBT 51,961 33,573 42,968 43,452 41,356 35,064 35,856 6.37%
Tax -11,518 -9,580 -11,714 -10,685 -9,122 -8,374 -8,686 4.81%
NP 40,442 23,993 31,253 32,766 32,233 26,689 27,169 6.84%
-
NP to SH 40,829 25,156 31,253 32,766 32,233 26,689 27,169 7.01%
-
Tax Rate 22.17% 28.53% 27.26% 24.59% 22.06% 23.88% 24.22% -
Total Cost 433,869 294,549 210,452 135,149 123,328 106,553 112,958 25.11%
-
Net Worth 474,230 451,913 268,509 187,436 179,125 167,965 162,405 19.53%
Dividend
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Div - - - 7,404 - - - -
Div Payout % - - - 22.60% - - - -
Equity
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Net Worth 474,230 451,913 268,509 187,436 179,125 167,965 162,405 19.53%
NOSH 278,959 278,959 278,959 138,841 138,856 138,814 138,807 12.32%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 8.53% 7.53% 12.93% 19.51% 20.72% 20.03% 19.39% -
ROE 8.61% 5.57% 11.64% 17.48% 17.99% 15.89% 16.73% -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 170.03 114.19 144.93 120.94 112.03 95.99 100.95 9.06%
EPS 14.49 8.60 18.72 23.60 23.21 19.23 19.57 -4.88%
DPS 0.00 0.00 0.00 5.33 0.00 0.00 0.00 -
NAPS 1.70 1.62 1.61 1.35 1.29 1.21 1.17 6.41%
Adjusted Per Share Value based on latest NOSH - 138,912
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 49.27 33.09 25.11 17.44 16.16 13.84 14.56 22.50%
EPS 4.24 2.61 3.25 3.40 3.35 2.77 2.82 7.02%
DPS 0.00 0.00 0.00 0.77 0.00 0.00 0.00 -
NAPS 0.4926 0.4694 0.2789 0.1947 0.1861 0.1745 0.1687 19.53%
Price Multiplier on Financial Quarter End Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 -
Price 2.20 2.06 2.72 3.17 2.55 2.36 2.10 -
P/RPS 1.29 1.80 1.88 2.62 2.28 2.46 2.08 -7.64%
P/EPS 15.03 22.84 14.51 13.43 10.99 12.27 10.73 5.77%
EY 6.65 4.38 6.89 7.44 9.10 8.15 9.32 -5.46%
DY 0.00 0.00 0.00 1.68 0.00 0.00 0.00 -
P/NAPS 1.29 1.27 1.69 2.35 1.98 1.95 1.79 -5.30%
Price Multiplier on Announcement Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 17/11/17 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 21/11/11 -
Price 2.20 2.10 2.70 3.01 2.56 2.28 2.10 -
P/RPS 1.29 1.84 1.86 2.49 2.29 2.38 2.08 -7.64%
P/EPS 15.03 23.29 14.41 12.75 11.03 11.86 10.73 5.77%
EY 6.65 4.29 6.94 7.84 9.07 8.43 9.32 -5.46%
DY 0.00 0.00 0.00 1.77 0.00 0.00 0.00 -
P/NAPS 1.29 1.30 1.68 2.23 1.98 1.88 1.79 -5.30%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment